HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masaki Shimoji Selected Research

rociletinib

4/2016Oncogene swap as a novel mechanism of acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitor in lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masaki Shimoji Research Topics

Disease

17Lung Neoplasms (Lung Cancer)
09/2023 - 02/2012
12Neoplasms (Cancer)
09/2023 - 12/2011
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2022 - 01/2016
3Adenocarcinoma
03/2020 - 10/2017
3Adenocarcinoma of Lung
01/2019 - 01/2016
2Cysts
04/2014 - 12/2011
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2021
1Chronic Obstructive Pulmonary Disease (COPD)
09/2021
1Disease Progression
10/2020
1Amyloidosis
06/2019
1Lymphoma (Lymphomas)
06/2019
1Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
06/2019
1Interstitial Lung Diseases (Interstitial Lung Disease)
10/2017
1Neoplasm Metastasis (Metastasis)
10/2016
1Melanoma (Melanoma, Malignant)
01/2016
1Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar)
02/2012
1Adenosquamous Carcinoma
12/2011

Drug/Important Bio-Agent (IBA)

8Tyrosine Kinase InhibitorsIBA
09/2023 - 12/2015
3AfatinibIBA
12/2021 - 12/2015
3ErbB Receptors (EGF Receptor)IBA
12/2018 - 04/2016
2Biomarkers (Surrogate Marker)IBA
09/2023 - 10/2018
2osimertinibIBA
01/2021 - 04/2016
2Proteins (Proteins, Gene)FDA Link
01/2019 - 10/2016
2LigandsIBA
11/2017 - 01/2016
2MucinsIBA
04/2014 - 12/2011
1mobocertinibIBA
09/2023
1tepotinibIBA
11/2022
1capmatinibIBA
11/2022
1Erlotinib Hydrochloride (CP 358,774)FDA Link
12/2021
1Hemoglobins (Hemoglobin)IBA
09/2021
1adagrasibIBA
01/2021
1sotorasibIBA
01/2021
1fibrin fragment D (D-dimer)IBA
11/2020
1Fibrinogen (Factor I)FDA Link
11/2020
1Circulating Tumor DNAIBA
10/2020
1Methylnitronitrosoguanidine (MNNG)IBA
10/2019
1Amyloid (Amyloid Fibrils)IBA
06/2019
1HM781-36BIBA
12/2018
1RNA (Ribonucleic Acid)IBA
10/2018
1Gefitinib (Iressa)FDA Link
01/2018
1dacomitinibIBA
01/2018
1Therapeutic UsesIBA
01/2018
1Granzymes (Granzyme)IBA
11/2017
1ChemokinesIBA
11/2017
1Interferon-gamma (Interferon, gamma)IBA
11/2017
1Carcinoembryonic AntigenIBA
10/2017
1Transforming Growth Factor beta (TGF-beta)IBA
01/2017
1Dasatinib (BMS 354825)FDA Link
01/2017
1src-Family KinasesIBA
01/2017
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2017
1Mutant Proteins (Protein, Mutant)IBA
10/2016
1rociletinibIBA
04/2016
1AntibodiesIBA
01/2016
1VimentinIBA
01/2016
1neratinibIBA
12/2015
1KinesinsIBA
02/2012
1Anaplastic Lymphoma KinaseIBA
02/2012
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
02/2012

Therapy/Procedure

3Therapeutics
01/2021 - 10/2016
2Segmental Mastectomy (Lumpectomy)
03/2020 - 11/2014
1Aftercare (After-Treatment)
12/2021
1Renal Dialysis (Hemodialysis)
06/2019